These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 32303621

  • 1. British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease.
    Smith D, Du Rand I, Addy CL, Collyns T, Hart SP, Mitchelmore PJ, Rahman NM, Saggu R.
    Thorax; 2020 May; 75(5):370-404. PubMed ID: 32303621
    [No Abstract] [Full Text] [Related]

  • 2. BTS guideline for the use of long-term macrolides.
    Congleton J.
    Drug Ther Bull; 2021 May; 59(5):67-68. PubMed ID: 33753351
    [No Abstract] [Full Text] [Related]

  • 3. British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease.
    Smith D, Du Rand IA, Addy C, Collyns T, Hart S, Mitchelmore P, Rahman N, Saggu R.
    BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32332022
    [Abstract] [Full Text] [Related]

  • 4. BTS guideline on long-term macrolides in adults with respiratory disease: not quite a panacea.
    Smith D.
    Thorax; 2020 May; 75(5):405-406. PubMed ID: 32303622
    [Abstract] [Full Text] [Related]

  • 5. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P, Fabbri LM, Bush A.
    Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
    [Abstract] [Full Text] [Related]

  • 6. [Immunomodulating effects of macrolides: areas of possible clinical use in pulmonology].
    Sinopal'nikov AI.
    Ter Arkh; 2011 Jul; 83(8):10-20. PubMed ID: 21961326
    [Abstract] [Full Text] [Related]

  • 7. Role of long term antibiotics in chronic respiratory diseases.
    Suresh Babu K, Kastelik J, Morjaria JB.
    Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
    [Abstract] [Full Text] [Related]

  • 8. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
    Bush A.
    Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
    [Abstract] [Full Text] [Related]

  • 9. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ, McSharry C, Chaudhuri R, Farrow S, Thomson NC.
    Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
    [Abstract] [Full Text] [Related]

  • 10. Macrolides: a treatment alternative for bronchiolitis obliterans organizing pneumonia?
    Stover DE, Mangino D.
    Chest; 2005 Nov; 128(5):3611-7. PubMed ID: 16304320
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Zhuo GY, He Q, Xiang-Lian L, Ya-Nan Y, Si-Te F.
    Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
    [Abstract] [Full Text] [Related]

  • 13. [Application progress of macrolide sustained therapy for bronchiectasis].
    Fan L, Xu J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):48-50. PubMed ID: 24694975
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacotherapy for lower respiratory tract infections.
    Liapikou A, Torres A.
    Expert Opin Pharmacother; 2014 Nov; 15(16):2307-18. PubMed ID: 25216725
    [Abstract] [Full Text] [Related]

  • 15. [Clinical basis of macrolides apply in diseases of the respiratory tract].
    Płusa T.
    Pol Merkur Lekarski; 2008 Nov; 25(149):432-6. PubMed ID: 19177783
    [Abstract] [Full Text] [Related]

  • 16. Use of macrolides in lung diseases: recent literature controversies.
    Silva Filho LV, Pinto LA, Stein RT.
    J Pediatr (Rio J); 2015 Nov; 91(6 Suppl 1):S52-60. PubMed ID: 26354869
    [Abstract] [Full Text] [Related]

  • 17. [Chinese expert consensus for non-antiinfective effects and clinical use of macrolides].
    Lin JT, Zhang YM, Zhou X, Wang CZ, Huang M, Liu CT, Wu CG, Wan HY, Yu WC, Dai YR.
    Zhonghua Nei Ke Za Zhi; 2017 Jul 01; 56(7):546-557. PubMed ID: 28693067
    [Abstract] [Full Text] [Related]

  • 18. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.
    Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K.
    Eur J Clin Pharmacol; 2012 May 01; 68(5):479-503. PubMed ID: 22105373
    [Abstract] [Full Text] [Related]

  • 19. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
    King P.
    Drugs; 2007 May 01; 67(7):965-74. PubMed ID: 17488142
    [Abstract] [Full Text] [Related]

  • 20. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.
    Eraković Haber V, Bosnar M, Kragol G.
    Future Med Chem; 2014 Apr 01; 6(6):657-74. PubMed ID: 24895894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.